Bipolar Disorder Treatment Maplewood, NJ

Bipolar disorder treatment Maplewood NJ residents can begin with a free 15-minute call, before any paperwork or insurance question.

Book a free 15-min call→

• APA + AAFP guideline–aligned

• Lithium + mood-stabilizer expertise

• IPSRT + FFT coordination

Bipolar disorder is a chronic, recurrent mood disorder characterized by episodes of mania or hypomania that alternate with episodes of depression. It affects roughly 2.8% of U.S. adults in any given year and typically emerges in late adolescence or early adulthood — the median age of onset is 25. Despite how commonly the word gets used colloquially to describe moodiness, irritability, or ordinary mood swings, bipolar disorder is a specific mental health condition with defined DSM-5-TR criteria, identifiable neurobiology, and well-established treatment pathways.

The stakes of getting bipolar disorder treatment right are high. Roughly one in three patients will make a lifetime suicide attempt — one of the highest rates in all of psychiatry — and lifetime suicide mortality is substantially elevated. Untreated or under-treated bipolar disorder also produces cumulative cognitive and functional impact across decades, with each unmanaged episode potentially contributing to more severe future presentations. On the other hand, well-managed bipolar disorder is compatible with full functioning, career stability, and satisfying relationships for most patients. The difference is the quality and consistency of care.

This page covers what we do at our Maplewood, NJ office and over NJ-wide telehealth: diagnostic workup, first-line mood stabilizer pharmacotherapy, when and how to use antidepressants safely, bipolar disorder therapy coordination with IPSRT and FFT, monitoring protocols, lifestyle foundations that meaningfully reduce relapse, and crisis planning. Bipolar disorder is specifically named in Teresa's clinical focus — not a condition we see occasionally, but one we treat week in and week out.

Bipolar I disorder requires at least one full manic episode lasting at least seven days (or any duration if hospitalization is required), typically accompanied by episodes of major depression. Manic episodes are severe — elevated or irritable mood, grandiosity, decreased need for sleep, pressured speech, racing thoughts, distractibility, increased goal-directed activity, and impulsive behavior causing significant functional impairment, dangerous consequences, or psychotic features. Bipolar I is the classic presentation and what most people picture.

Bipolar II disorder requires at least one hypomanic episode (less severe, typically four days) plus at least one major depressive episode. Hypomania does not cause the severe impairment or hospitalization of mania — it often feels productive, energized, and creative to the patient, which is why bipolar II is frequently under-diagnosed. Patients present asking for help with depression and the hypomanic episodes go unreported because they don't feel like a problem. The depressive episodes of bipolar II are typically more frequent and more disabling than those of unipolar major depression, and the suicide risk is comparable to bipolar I.

Cyclothymic disorder involves chronic fluctuations between mild hypomanic symptoms and mild depressive symptoms for at least two years (one year in adolescents), without meeting full criteria for either. Cyclothymia is under-diagnosed because the mood swings are milder and the individual episodes are less severe — but the cumulative functional impact is real, and cyclothymia converts to bipolar I or II in a meaningful percentage of cases over time.

Bipolar disorder symptoms differ enough across these subtypes that a plan built for one can fail badly for another. The spectrum also includes mixed features (depression with concurrent manic symptoms, where lithium often works less well), rapid cycling (four or more episodes per year), and bipolar depression with seasonal pattern. Getting the subtype right shapes the treatment plan materially, because bipolar treatment is subtype-specific in a way that unipolar depression treatment is not.

Several features in a depressive episode raise the probability of bipolar II rather than unipolar major depression. The AAFP bipolar checklist highlights: onset before age 25, recurrent episodes (three or more), antidepressants that caused activation or mood elevation beyond typical response, family history of bipolar disorder or completed suicide, atypical features (hypersomnia, hyperphagia, leaden paralysis, rejection sensitivity), seasonal pattern, brief depressive episodes lasting weeks rather than months, and post-partum onset.

If three or more are present, the workup for bipolar II should be more aggressive — detailed MDQ review, family history conversation, and often structured longitudinal observation before committing to standard antidepressant monotherapy. Starting an SSRI in an undiagnosed bipolar patient can precipitate a manic episode; the risk is real enough that we screen carefully before routine antidepressant prescribing in patients with these risk factors.

Several other atypical antipsychotics have FDA indications or strong evidence. Lurasidone (Latuda) has strong evidence for bipolar depression with a relatively favorable metabolic profile. Aripiprazole (Abilify) and cariprazine (Vraylar) are used for maintenance and mania. Olanzapine (Zyprexa) has strong efficacy but the heaviest metabolic burden and is often reserved for cases where other options have failed. Olanzapine-fluoxetine combination (Symbyax) is FDA-approved specifically for bipolar depression.

Metabolic monitoring applies across the class: weight, waist circumference, fasting glucose, HbA1c, and lipid panel at baseline and annually, more frequently during dose changes. Long-term use of higher-potency agents also warrants monitoring for extrapyramidal symptoms and tardive dyskinesia. Choice within the class is driven primarily by side-effect profile matched to patient-specific concerns rather than large efficacy differences.

Evidence based psychotherapy for bipolar disorder includes Cognitive Behavioral Therapy and Dialectical Behavior Therapy, alongside two approaches built specifically for bipolar illness — Interpersonal and Social Rhythm Therapy and Family-Focused Therapy. All four have behavioral health evidence behind them, and all four run alongside medication rather than instead of it. Evidence based psychotherapy also supplies the practical tools that make the medication work better: mood tracking, recognizing patterns, and catching an episode in its first week rather than its third.

Cognitive Behavioral Therapy (CBT) adapted for bipolar disorder — typically 12–14 sessions of talk therapy — focuses on recognizing early warning signs of mood episodes, maintaining routines, challenging distorted thinking, and building positive coping skills for the functional impacts of the illness. CBT reduces depressive relapse and improves medication adherence.

Dialectical Behavior Therapy (DBT) is also used for bipolar disorder, though its role is narrower than CBT's. DBT was built for emotion dysregulation rather than for mood episodes, so it does not replace a mood stabilizer. It earns its place where impulsivity, self-harm, chronic suicidal thinking, or a co-occurring personality disorder sit alongside the bipolar diagnosis — and the four skills modules (distress tolerance, emotion regulation, interpersonal effectiveness, mindfulness) give patients something concrete to do in the hours when a mood shift is building rather than after it has arrived. DBT adapted for adolescents with bipolar disorder has the strongest evidence of any DBT application in this population.

Interpersonal and Social Rhythm Therapy (IPSRT) is bipolar-specific and addresses the circadian and social-rhythm disruptions that commonly trigger mood episodes. Bipolar mood cycles are tightly linked to sleep patterns, meal timing, light exposure, and social engagement. IPSRT teaches patients to track and stabilize these rhythms and has documented efficacy in reducing relapse.

Family-Focused Therapy (FFT) is a 21-session intervention for bipolar patients and their families. It improves outcomes through psychoeducation, family communication training, and problem-solving skills, with studies showing roughly 30–35% lower relapse rates compared to standard care. FFT is particularly valuable for adolescents and young adults living at home during a first or early episode.

Teresa provides brief supportive work and motivational support during medication visits, in a nonjudgmental environment where the goal is that patients feel heard rather than processed. Bipolar disorder therapy and medication are complementary rather than alternative, and the best outcomes come from having both running. For structured CBT, DBT, IPSRT, or FFT, we refer to New Jersey specialists with the specific training and current openings. Group psychoeducation is another evidence-based option where available.

This is an outpatient mental health clinic. Knowing what that does and does not include saves people weeks of the wrong search.

What happens here: psychiatric evaluation, diagnosis, medication management, laboratory monitoring, brief supportive therapy, safety planning, therapy coordination, and ongoing outpatient care.

What we refer out:

• Inpatient hospitalization. For acute mania, psychosis, or acute suicide risk, a hospital is the right answer rather than a follow-up appointment.

• Partial hospitalization and intensive outpatient programs. Useful as a step down from hospitalization or a step up from weekly visits.

• Residential bipolar disorder treatment center programs. Some patients benefit from a structured residential setting, particularly where substance abuse co-occurs. New Jersey has a number of treatment centers offering this, and the right treatment center depends on level of care, insurance coverage, and whether the program handles co-occurring substance use.

• ECT, TMS, and ketamine or esketamine. Specialist programs, covered below.

• Structured CBT, DBT, IPSRT, and FFT. Delivered by therapists with that specific training.

New Jersey treatment centers vary enormously — some are general mental health treatment centers, some specialize in co-occurring substance use, and some are primarily addiction treatment centers that also accept bipolar admissions. What a treatment center is actually equipped for matters more than its marketing, and the questions worth asking are whether a psychiatrist manages medication on site, whether they handle your specific comorbidity, and what the step-down plan looks like.

If you are doing this search at two in the morning, which is when a lot of people do it, the RWJBarnabas Health Behavioral Health Access Center provides 24-hour support for finding treatment at 1-800-300-0628. It is an intake and consultation line rather than a crisis line — for crisis it is 988 — but it can tell you what level of care exists and where, at an hour when almost nothing else answers.

If you are comparing a treatment center against outpatient bipolar treatment and cannot tell which you need, the free 15-minute call is a reasonable place to sort it out — even when the answer is somewhere other than here. Care providers who only ever recommend their own level of care are not being straight with you.

Irritability is a core feature of both mania and mixed states, and it is frequently what brings a family to the point of insisting on treatment. It is worth being precise about this: anger management classes, while useful for some people, do not treat bipolar irritability, because the irritability is a symptom of an unstable mood state rather than a skills deficit. Stabilize the mood and the irritability usually recedes on its own.

That does not mean the relational damage takes care of itself. Chronic stress on a marriage, damaged friendships, and the self esteem cost of behavior you regret afterward all persist after the episode ends, and they are what bipolar disorder therapy and family work are for. Emotional stability is the medication's job; repairing what happened during the unstable periods is therapy's.

Bipolar medication management includes standing laboratory monitoring that varies by medication but generally covers a basic metabolic panel, TSH and free T4, fasting glucose and HbA1c, fasting lipid panel, complete blood count, liver function tests, pregnancy status in women of reproductive age, and drug levels for lithium and valproate. Baseline EKG is recommended for patients over 40 or with cardiovascular risk factors before starting certain atypical antipsychotics. For patients on carbamazepine in populations of Asian ancestry, HLA-B*1502 genetic testing is recommended before starting due to elevated Stevens-Johnson syndrome risk.

Frequency is typically baseline workup at initiation, a 3-month recheck during dose titration, and 6-monthly intervals once stable. We order labs through your preferred laboratory and incorporate results into visit planning. Cardiovascular screening matters particularly because bipolar disorder is associated with roughly twice the general-population rate of cardiovascular disease, partly from metabolic medication effects and partly from the underlying illness.

Suicide risk in bipolar disorder is substantial — roughly one in three patients will make a lifetime suicide attempt, with risk particularly elevated during depressive episodes, mixed features, early in treatment, and during significant life transitions. We build explicit safety planning into care: identifying the personal symptoms that signal an episode beginning, reducing access to means during high-risk periods, involving family members with patient consent, and establishing clear escalation pathways.

Lithium's documented suicide-reduction effect is one reason we recommend it over alternatives when clinically appropriate. A roughly 50% reduction in completed suicide is one of the strongest treatment effects in all of medicine and factors heavily into the risk-benefit conversation at the time of prescribing.

Bipolar disorder is explicitly named in Teresa's clinical focus, and bipolar disorder therapy coordination is part of what that means in practice. Initial evaluation is 60–90 minutes covering DSM-5-TR criteria across the spectrum, MDQ screening, detailed mood-episode history with family input when available, medical history, medication history, substance use, and suicide-risk assessment with the Columbia Suicide Severity Rating Scale. Baseline laboratory workup is ordered as indicated.

Follow-up cadence during initial titration is every 2–4 weeks. Once stable, visits move to every 4–8 weeks for the first year and every 2–3 months thereafter, with standing 6-monthly laboratory monitoring. Visits are substantive: 30–45 minutes covering mood symptoms, sleep and circadian status, medication tolerance, lab review, life stressors, and any concerning cycling patterns. The PMHNP model allows prescribing and brief supportive therapy in the same visit; for structured therapy we refer and coordinate with NJ specialists.

Hybrid telehealth and in person care works well for most stable patients. Initial evaluations and periodic check-ins often benefit from the in person format; routine medication management, therapy coordination, and rapid-contact visits during warning-sign periods suit telehealth. For patients with a history of rapid destabilization we lean toward more frequent in person contact.

Teresa is a Board-Certified Psychiatric Mental Health Nurse Practitioner providing compassionate care in a supportive environment, with the continuity that a chronic mental health condition actually requires — the same clinician across years, not a rotating roster. Long clinical practice with mood disorders is the relevant medical expertise here; bipolar disorder rewards a prescriber who has watched a lot of these illnesses unfold over time.

Therapeutic relationships matter more in a lifelong condition than in a short course of care. The aim is a nonjudgmental space where patients feel valued rather than managed — where you can report a bad month, or that you stopped a medication, without bracing for a lecture. People hide relapses from mental health professionals who make them feel judged, and hidden relapses are dangerous ones.

Bipolar disorder rarely arrives alone. Anxiety disorders co-occur in a majority of patients, substance use disorders in roughly a third, and ADHD more often than the overlap is recognized. Treating the bipolar illness in isolation while other mental health challenges go unaddressed is a common reason treatment plateaus.

This clinic handles the psychiatric care for the whole picture rather than splitting it across providers — anxiety, depression, and ADHD are all treated here, with bipolar disorder as the organizing diagnosis when it is present. Treating bipolar disorder alongside those conditions is the norm here rather than a complication. Where the co-occurring condition needs mental health services we do not provide — structured therapy, intensive programs, substance use treatment — we refer and coordinate rather than hand you a list. Those mental health services exist across New Jersey and we know which ones answer the phone.

One framing worth correcting: bipolar disorder is a mental illness in the clinical sense, like diabetes is a metabolic illness, and the word carries more weight than it should. Mental disorders with this much evidence behind their treatment are not a verdict on character. Evidence based therapies and the right medication produce ordinary lives, reliably.

How do I know if my depression is actually bipolar II?

The tells are in the history rather than the current episode: depression starting before age 25, three or more recurrences, brief episodes, atypical features like oversleeping and overeating, a family history of bipolar disorder, postpartum onset, or an antidepressant that made you unusually energized. Any of those warrants an MDQ and a careful conversation about periods when you needed less sleep and felt unusually productive.

Is lithium safe? What are the side effects?

Lithium is safe when monitored, and it is the only mood stabilizer with clear evidence of reducing suicide. It needs periodic blood levels plus thyroid and kidney checks, typically every six months once stable. Common side effects are tremor, increased thirst and urination, GI upset, and some weight gain. The reason we still reach for it first in many cases is that the long-term outcome data is better than for anything else.

Can I get pregnant while taking bipolar medications?

Yes, but the plan needs to be made before conception rather than after. Valproate is contraindicated in pregnancy. Lamotrigine has a comparatively favorable profile. Lithium carries a documented but often manageable risk that is weighed against the substantial risk of relapse if medication stops. Stopping abruptly to protect a pregnancy is frequently the more dangerous choice. We coordinate with your obstetric care providers.

Can antidepressants trigger mania?

Yes, particularly without mood-stabilizer coverage. Tricyclics and venlafaxine carry the highest switch risk; SSRIs and bupropion less. This is why we screen for bipolar disorder before prescribing antidepressants for depression, and why an antidepressant in bipolar illness is given alongside a stabilizer with explicit monitoring.

What's the difference between bipolar I and bipolar II?

Bipolar I involves at least one full manic episode — severe, at least seven days, often with hospitalization or psychosis. Bipolar II involves hypomania, which is shorter and less impairing, plus major depression. Bipolar II is not the milder illness: the depression is usually more frequent and more disabling, and the suicide risk is comparable.

How often will I need blood tests?

Baseline before starting, a recheck around three months during titration, then roughly every six months once stable. Lithium and valproate need drug levels; lithium adds thyroid and kidney function; atypical antipsychotics add metabolic labs. It is less onerous in practice than it sounds on paper.

What's rapid cycling and how is it treated?

Four or more mood episodes in a year. Lithium works less well; valproate, lamotrigine, and atypical antipsychotics are generally preferred, and antidepressants are used cautiously or avoided because they can amplify the cycling. Thyroid function is always checked, since subclinical hypothyroidism contributes.

Can I drink alcohol on mood stabilizers?

The honest answer is that alcohol works against every part of the treatment plan — it disrupts sleep architecture, reduces mood stabilizer efficacy, and increases impulsivity during vulnerable periods. We would rather have a realistic conversation about reducing it than issue a rule you won't follow.

Will I need to be on medication forever?

Bipolar disorder is a lifelong condition and maintenance medication is the norm, because relapse rates after discontinuation are high. That said, regimens change — doses come down, agents get simplified, and some patients need much less at fifty than at twenty-five. We revisit it rather than treating the first prescription as permanent.

What if I go into crisis — who do I call?

988 any time, day or night. 911 or the nearest emergency room if you are in immediate danger. Your county's Psychiatric Emergency Screening Service for in-person or mobile crisis response. This clinic is not a 24/7 service, so please use those lines first and tell us afterward — we coordinate with crisis teams and adjust the plan at the next visit. For the different problem of finding treatment at an odd hour rather than managing an emergency, the RWJBarnabas Health Behavioral Health Access Center offers 24-hour consultative support at 1-800-300-0628.